Additional Resources Semaglutide Clinical Trial New England Journal of Medicine Tirzepatide Clinical Trial New England Journal of Medicine Medically authored by Dr
There is no universally right answer, only the one that works best for each patient
Studies indicate that it exerts multi-target effects on glucose and lipid metabolism by modulating blood glucose and lipid levels, optimizing insulin secretion, improving cortisol profiles, and restoring vascular endothelial function
Keep in mind that, of the two semaglutides, Wegovy is the only one FDA-approved for weight loss
Because injections are thought to be cumbersome, and painful, and expensive
Unlocking the path to obesity treatment: GLP-1 Drugs have proven remarkably effective in managing weight, rivaling surgical procedures like gastric bypass